Parkside Financial Bank & Trust »

Lenz Therapeutics shares owned by Parkside Financial Bank & Trust

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Parkside Financial Bank & Trust from 13F filings

Historical chart of Parkside Financial Bank & Trust investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Parkside Financial Bank & Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Parkside Financial Bank & Trust

Quarter filed Position value Share count Share price at filing
2026-03-31 $503 55 9.16

More positions owned by Parkside Financial Bank & Trust

Blackrock (BLK)
Apple (AAPL)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Roivant Sciences SHS (ROIV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Microsoft Corporation (MSFT)
Ishares Tr Rus 1000 Val Etf (IWD)
NVIDIA Corporation (NVDA)
Vanguard Scottsdale Fds Vng Rus1000idx (VONE)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Bd Index Fds Intermed Term (BIV)
State Str Spdr S&p 500 Etf T Put Put Option (Principal) (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Eafe Etf (EFA)

View all positions for Parkside Financial Bank & Trust

Top funds holding Lenz Therapeutics

RA Capital Management
FMR
Falcon Edge Capital
Versant Venture Management
BlackRock
Squarepoint Ops
Vanguard Group
Standard Life Aberdeen
Franklin Resources
Vanguard Capital Management
72 Investment Holdings
Millennium Management
CAM Group Holding A/S
Morgan Stanley
Bank of America Corporation

View all funds holding Lenz Therapeutics